Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Life changes impact budgeting in many ways. This intro shows how to anticipate shifts, recalibrate goals, and keep your finances stable.
22,101 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
When markets feel bumpy, dividend stocks uncertain times can anchor a portfolio. Here are two dependable picks—Coca-C...
Rising retiree incomes are pushing more Social Security benefits into taxation. Here’s how the rules work, who is aff...
Insider trades can reveal more than cash changing hands. Explore how a recent Warby Parker director sold shares, what...
Analysts warn that the Social Security funding gap could reach a tipping point in the early 2030s. If policy action s...
A new Fidelity study finds that Americans with a formal retirement plan report higher confidence in their financial f...
A high-profile operation in Mexico ends with the death of a cartel leader, prompting a shelter-in-place advisory for ...
Bloom Energy and Plug Power are leading the move toward cleaner power. This guide breaks down their business models, ...
When a CEO exits at a major fintech-adjacent firm, investors scramble for context. This article digs into what the de...
A recent sale of 25,000 ALHC shares by Alignment Healthcare’s vice chairman has investors wondering about the stock’s...
As AI reshapes how we search, socialize, and transact, two tech giants stand out: Alphabet and Meta Platforms. This a...
A potential federal shift on cannabis could redefine the playing field for Canopy Growth, Tilray, and Green Thumb. Th...